BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28449211)

  • 41. Reconsidering the bio-detection of tolerance in renal transplantation.
    Braza F; Soulillou JP; Brouard S
    Chimerism; 2013; 4(1):15-7. PubMed ID: 23712257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thoracic organ transplantation: laboratory methods.
    Patel JK; Kobashigawa JA
    Methods Mol Biol; 2013; 1034():127-43. PubMed ID: 23775735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Finding the right time for weaning off immunosuppression in solid organ transplant recipients.
    Orlando G
    Expert Rev Clin Immunol; 2010 Nov; 6(6):879-92. PubMed ID: 20979553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transplantation tolerance.
    Brinkman C; Burrell B; Scalea J; Bromberg JS
    Methods Mol Biol; 2013; 1034():85-101. PubMed ID: 23775732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor.
    Gajewski JL; Ippoliti C; Ma Y; Champlin R
    Am J Hematol; 2002 Dec; 71(4):311-3. PubMed ID: 12447962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor.
    Schwarz C; Lawitschka A; Böhmig GA; Dauber EM; Greinix H; Kozakowski N; Mühlbacher F; Berlakovich GA; Wekerle T
    Transplantation; 2016 Oct; 100(10):2219-21. PubMed ID: 27136263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation.
    Koshiba T; Li Y; Takemura M; Wu Y; Sakaguchi S; Minato N; Wood KJ; Haga H; Ueda M; Uemoto S
    Transpl Immunol; 2007 Feb; 17(2):94-7. PubMed ID: 17306739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5.
    Dilek N; Poirier N; Usal C; Martinet B; Blancho G; Vanhove B
    J Immunol; 2012 May; 188(9):4209-16. PubMed ID: 22450806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers and immunopathology of tolerance.
    Mastoridis S; Martínez-Llordella M; Sanchez-Fueyo A
    Curr Opin Organ Transplant; 2016 Feb; 21(1):81-7. PubMed ID: 26709578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 'biomarker signature' for tolerance in transplantation.
    Hernandez-Fuentes MP; Lechler RI
    Nat Rev Nephrol; 2010 Oct; 6(10):606-13. PubMed ID: 20717098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A need for biomarkers of operational tolerance in liver and kidney transplantation.
    Londoño MC; Danger R; Giral M; Soulillou JP; Sánchez-Fueyo A; Brouard S
    Am J Transplant; 2012 Jun; 12(6):1370-7. PubMed ID: 22486792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidental detection of operational tolerance in a deceased donor kidney transplant recipient lost to follow-up for more than 10 years: A case report and literature review.
    Roy S; Chowdhury MH; Basuli D; Adapa S; Bodziak K
    Clin Nephrol Case Stud; 2023; 11():12-16. PubMed ID: 36844261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acquired tolerance, allograft "acceptance," and immune suppression.
    Starzl TE
    Transplant Proc; 1998 Nov; 30(7):3845. PubMed ID: 9838681
    [No Abstract]   [Full Text] [Related]  

  • 59. Telling the tiger by its stripes: mapping the genomics of kidney graft tolerance in real time.
    Roden DL; Grey ST
    Kidney Int; 2015 May; 87(5):875-7. PubMed ID: 25951065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft.
    Baron D; Ramstein G; Chesneau M; Echasseriau Y; Pallier A; Paul C; Degauque N; Hernandez-Fuentes MP; Sanchez-Fueyo A; Newell KA; Giral M; Soulillou JP; Houlgatte R; Brouard S
    Kidney Int; 2015 May; 87(5):984-95. PubMed ID: 25629549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.